Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors

Treatment using oncolytic virus as a new tumor immunologic agent has made continuous breakthroughs in basic and clinical research of tumor in recent years, and it is expected to play an important role in cancer immunotherapy in the future. At present, there are 4 oncolytic viruses approved for marke...

Полное описание

Библиографические подробности
Главный автор: Expert Committee on Immunotherapy of Chinese Society of Clinical Oncology , Professional Committee on Cancer Biotherapy of Shanghai Anticancer Association
Формат: Статья
Язык:English
Опубликовано: Editorial Office of China Oncology 2023-05-01
Серии:Zhongguo aizheng zazhi
Предметы:
Online-ссылка:http://www.china-oncology.com/fileup/1007-3639/PDF/1686896465477-1251193185.pdf